Published in Crit Rev Immunol on January 01, 1991
Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev (2006) 3.30
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A (1993) 2.91
Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. Proc Natl Acad Sci U S A (1991) 2.68
NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med (1994) 2.61
Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol (1997) 2.35
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci U S A (1992) 2.08
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med (1994) 1.77
Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci U S A (1993) 1.77
A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med (1995) 1.44
Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol (1995) 1.40
Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci U S A (1994) 1.28
NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol (2006) 1.22
Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements. J Exp Med (1993) 1.21
Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells. Proc Natl Acad Sci U S A (1992) 1.09
Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine (Baltimore) (2015) 0.84
A novel role for MHC class II antigens: evidence implicating a protective effect on tumour cells against cytotoxicity by NK and LAK cells. Immunology (1994) 0.84
Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression. Immunology (1994) 0.80
Preferential interaction of a novel tumor surface protein (p38.5) with naive natural killer cells. J Exp Med (1997) 0.79
Interaction between circulating cancer cells and platelets: clinical implication. Chin J Cancer Res (2015) 0.78
Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors. Immunology (1993) 0.78
Antigen shedding and metastasis of tumour cells. Clin Exp Immunol (1991) 0.77
Mechanisms by which HLA-class II molecules protect human B lymphoid tumour cells against NK- and LAK-mediated cytolysis. Immunology (1996) 0.76
Cellular Inclusions in Cerebral Lesions of Lethargic Encephalitis. Am J Pathol (1933) 5.91
Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med (2001) 5.29
NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol (1987) 3.06
Herpetic Infection of the Chorio-Allantoic Membrane of the Chick Embryo. Am J Pathol (1933) 2.54
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci U S A (1989) 2.32
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2. Proc Natl Acad Sci U S A (1991) 2.07
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody. Infect Immun (1990) 1.70
Waiting for coronary angiography: is there a clinically ordered queue? Lancet (2000) 1.58
Natural killing target antigens as inducers of interferon: studies with an immunoselected, natural killing-resistant human T lymphoblastoid cell line. J Immunol (1985) 1.52
INFECTION OF CHICKS AND CHICK EMBRYOS WITH RABIES. Science (1939) 1.50
Rating the appropriateness of coronary angiography, coronary angioplasty and coronary artery bypass grafting: the ACRE study. Appropriateness of Coronary Revascularisation study. J Public Health Med (1999) 1.36
The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing. J Immunol (1989) 1.30
Salbutamol in treatment of heart failure. Br Heart J (1980) 1.27
Dimeric and monomeric forms of HL-A antigens solubilized by detergent. J Immunol (1975) 1.17
The size and number of polypeptide chains in human serum low density lipoprotein. J Biol Chem (1972) 1.13
Double infection of tobacco protoplasts with brome mosaic virus and cowpea chlorotic mottle virus. Virology (1980) 1.12
Peptide-induced modulation of target cell sensitivity to natural killing. J Immunol (1992) 1.12
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure. Br Heart J (1985) 1.09
Magnitude and consequences of error in coronary angiography interpretation (the ACRE study). Am J Cardiol (2000) 1.08
What stops the flow of blood from the heart? Heart Vessels (1988) 1.05
Calcium antagonist drugs in chronic stable angina. Comparison of verapamil and nifedipine. Br Heart J (1981) 1.05
Treponema denticola as a model for polar adhesion and cytopathogenicity of spirochetes. Trends Microbiol (1994) 1.02
MHC class I expression and transport in a calnexin-deficient cell line. J Immunol (1995) 0.99
A study of chick-embryo-adapted rabies virus. Am J Pathol (1941) 0.99
Induction of drug metabolizing enzymes in human liver cell line Hep G2. FEBS Lett (1985) 0.97
Clinical studies with beta 2 adrenoceptor agonists in heart failure. Eur Heart J (1982) 0.95
Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses. Br Med J (Clin Res Ed) (1981) 0.94
Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma. Cancer Res (1979) 0.91
The role of the lysosome in natural killing: inhibition by lysosomotropic vital dyes. Immunology (1984) 0.91
Correlation of human CD56+ cell cytotoxicity and IFN-gamma production. Cytokine (2001) 0.90
Light scattering and hydrodynamic properties of linear and circular bacteriophage lambda DNA. Biopolymers (1971) 0.88
Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure. Am Heart J (1981) 0.88
Getting residents involved in research: a challenge in the era of managed care. Acad Med (1999) 0.88
B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation. J Immunol (1986) 0.86
Glutathione conjugation by isolated lung cells and the isolated, perfused lung. Effect of extracellular glutathione. Eur J Biochem (1984) 0.86
Lymphocyte stimulation in vitro: generation of cytotoxic effector lymphocytes using subcellular fractions of a lymphoid cell line. Cell Immunol (1975) 0.85
Xenobiotic metabolism by isolated intestinal epithelial cells from guinea-pigs. Biochem Pharmacol (1979) 0.85
Low angle light scattering studies on whole, half, and quarter molecules of T2 bacteriophage DNA. Biophys J (1989) 0.85
Immune complexes in ovarian cancer. Gynecol Oncol (1982) 0.84
Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol. Br Heart J (1983) 0.84
The purification of detergent-solubilized HL-A antigens by affinity chromatography with the hemagglutinin from Lens culinaris. J Immunol (1974) 0.84
Quantitation of secretory component levels in cyst fluids, ascitic fluids, and sera from ovarian adenocarcinoma patients. J Natl Cancer Inst (1978) 0.84
Detection of clinically significant coronary artery disease in hypertensive patients. Echocardiographic study. Br Heart J (1981) 0.83
Identification and purification of NK cells with lysosomotropic vital stains: correlation of lysosome content with NK activity. J Immunol (1985) 0.83
Human natural killing against ovarian carcinoma. Br J Cancer (1983) 0.83
Regulation of human natural killing by levamisole. Cancer Immunol Immunother (1982) 0.83
Characterization of a subset of human B lymphocytes interacting with natural killer cells. J Immunol (1991) 0.82
The mechanism of entry of viruses into plant protoplasts. Ciba Found Symp (1981) 0.82
Salbutamol in cardiogenic shock complicating acute myocardial infarction. Br Heart J (1980) 0.82
Differential expression of natural killer cell markers: human versus baboon. Transplantation (1996) 0.82
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias. Eur Heart J (1982) 0.81
Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients. Cancer Res (1979) 0.81
Myasthenia gravis in a cat. Vet Rec (1970) 0.81
The effect of a disinfectant/coolant irrigant on microbes isolated from dental unit water lines. Spec Care Dentist (2002) 0.81
Oxygen-reactive metabolites are not detected at the effector-target interface during natural killing. J Leukoc Biol (1986) 0.81
Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis. Cell Immunol (1996) 0.81
Quantitation of secretory protein levels by radioimmunoassay. J Immunol Methods (1978) 0.80
The effectiveness of N-acetylcysteine in isolated hepatocytes, against the toxicity of paracetamol, acrolein, and paraquat. Arch Toxicol (1984) 0.79
Quantitation and sorting of vitally stained natural killer cell-target cell conjugates by dual beam flow cytometry. Cytometry (1986) 0.79
Induction of procoagulant function in porcine endothelial cells by human natural killer cells. J Immunol (1997) 0.79
A method for the purification of large quantities of biologically active ribonucleic acid components from cowpea chlorotic mottle virus, a multicomponent plant virus. Z Naturforsch C (1977) 0.79
Study of secretory component in patients with metastatic breast cancer. Am J Obstet Gynecol (1979) 0.79
Stimulation of lymphocytes by allogeneic lymphocytes and lymphoblasts in the presence of anti-HLA antisera. Eur J Immunol (1976) 0.79
The influence of normal serum components on lymphocyte-mediated cytolysis in vitro. Transplantation (1974) 0.78
The role of calnexin in NK-target cell interaction. Immunol Lett (1998) 0.78
Characterization of acid-denatured DNA by low-angle light scattering. Biopolymers (1970) 0.78
Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation (1996) 0.78
The isolation of rat lung cells for the purpose of studying drug metabolism. Biochem Pharmacol (1982) 0.78
Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients. Cancer Res (1980) 0.77
Inhibition of human lymphoblastoid cell line proliferation by ascites fluids from ovarian cancer patients. Cancer Res (1980) 0.77
Induction of HLA-specific CTL to nonimmunogenic, heat-inactivated lymphocytes by interleukin 2. Transplantation (1990) 0.77
Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation. Drug Metab Dispos (1984) 0.76
Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure. Br J Clin Pharmacol (1987) 0.76
The serologic detection of HL-A antigens in human milk. Tissue Antigens (1974) 0.76
Extrahepatic sulfation and glucuronidation in the rat in vivo. Determination of the hepatic extraction ratio of harmol and the extrahepatic contribution to harmol conjugation. Biochem Pharmacol (1984) 0.76
Conjugation and excretion of metabolites of 7-hydroxycoumarin in the small intestine of rats and guinea-pigs. Biochem Pharmacol (1979) 0.75
Cross-reactivity of normal gastric tissue components with ovarian tumour-associated antigens. Br J Cancer (1980) 0.75
Polydispersity and excluded volume effects in sheared DNA fragments. Biophys J (1991) 0.75
Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function. Br Heart J (1985) 0.75
Regulation of human natural killing by lysosomotropic and thiol-reactive agents. Immunology (1985) 0.75
The humoral response to gynecologic malignancies and its role in the regulation of tumor growth: a review. Am J Reprod Immunol (1983) 0.75
Relation between intraventricular pressure and volume in diastole. Br Heart J (1990) 0.75
Incoordinate left ventricular wall motion after acute myocardial infarction. Serial echocardiographic assessment. Br Heart J (1984) 0.75
Activity of antibodies recovered from immune complexes of ovarian cancer patients. Cancer Immunol Immunother (1984) 0.75
Heat treatment of leukemic cell lines can increase their sensitivity to NK lysis. Cell Immunol (1995) 0.75
Conformation dependence of MHC class I in the modulation of target cell sensitivity to natural killing. Hum Immunol (1998) 0.75
Experimental hypertension and pregnancy in dogs. Am J Pathol (1941) 0.75
Quantitation of secretory protein levels by radioimmunoassay. Methods Enzymol (1981) 0.75
The solubilization of HLA antigens with detergents and partial characterization of the antigen-detergent complexes. Immunochemistry (1976) 0.75
Identification of tumor-associated antigens and their purification for cyst fluids of ovarian epithelial neoplasms. Gynecol Oncol (1980) 0.75
Cell-mediated cytotoxicity and the reorientation of effector cell granules towards the target cell are inhibited by the protonophore carbonylcyanide m-chlorophenylhydrazone. Hum Immunol (1988) 0.75
Intact guinea-pig intestinal cells as a model for studying drug metabolism [proceedings]. Biochem Soc Trans (1979) 0.75
Serologic assay of HL-A antigens in the presence of detergents. J Immunol (1973) 0.75
Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms. Am J Obstet Gynecol (1984) 0.75
Protein composition of unusual tobacco mosaic virus strains. Ann Appl Biol (1975) 0.75
Sequence relations and coding properties of a subgenomic RNA isolated from barley stripe mosaic virus. Virology (1983) 0.75
Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease. Blood Coagul Fibrinolysis (1996) 0.75
The effectiveness of different sulfate precursors in supporting extrahepatic sulfate conjugation. Biochem Pharmacol (1983) 0.75
Cross-reactions of HL-A antibodies. II. Continuous pH gradient elution. J Immunol (1972) 0.75